Zhejiang Tailin Bioengineering Co Ltd (300813) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.053x

Based on the latest financial reports, Zhejiang Tailin Bioengineering Co Ltd (300813) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.25 Million ≈ $6.18 Million USD) by net assets (CN¥804.29 Million ≈ $117.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Tailin Bioengineering Co Ltd (300813) market capitalisation for the company's overall valuation and market capitalisation.

Zhejiang Tailin Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhejiang Tailin Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Tailin Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Tailin Bioengineering Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Tailin Bioengineering Co Ltd (300813) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jinhong Fashion Group Co Ltd SHG:603518	-0.014x
Shanghai Hi-Road Food Technology Co. Ltd. SHE:300915	-0.003x
Ashiana Housing Limited NSE:ASHIANA	0.116x
Jinling Hotel Corp Ltd SHG:601007	0.053x
Maha Energy AB (publ) ST:MAHA-A	-0.019x
Sichuan Huiyuan Optical Com SHE:000586	0.036x
Komipharm International Co. Ltd KQ:041960	0.013x
Jerusalem TA:JBNK	0.033x

Annual Cash Flow Conversion Efficiency for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025. View Zhejiang Tailin Bioengineering Co Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥804.29 Million ≈ $117.69 Million	CN¥57.11 Million ≈ $8.36 Million	0.071x	+136.34%
2024-12-31	CN¥820.73 Million ≈ $120.10 Million	CN¥24.66 Million ≈ $3.61 Million	0.030x	+911.17%
2023-12-31	CN¥650.24 Million ≈ $95.15 Million	CN¥1.93 Million ≈ $282.70K	0.003x	-97.85%
2022-12-31	CN¥647.45 Million ≈ $94.74 Million	CN¥89.39 Million ≈ $13.08 Million	0.138x	+90.94%
2021-12-31	CN¥497.38 Million ≈ $72.78 Million	CN¥35.96 Million ≈ $5.26 Million	0.072x	-69.78%
2020-12-31	CN¥444.24 Million ≈ $65.01 Million	CN¥106.28 Million ≈ $15.55 Million	0.239x	+88.75%
2019-12-31	CN¥229.11 Million ≈ $33.53 Million	CN¥29.04 Million ≈ $4.25 Million	0.127x	-33.89%
2018-12-31	CN¥194.70 Million ≈ $28.49 Million	CN¥37.33 Million ≈ $5.46 Million	0.192x	+21.87%
2017-12-31	CN¥146.48 Million ≈ $21.44 Million	CN¥23.04 Million ≈ $3.37 Million	0.157x	-42.03%
2016-12-31	CN¥116.31 Million ≈ $17.02 Million	CN¥31.56 Million ≈ $4.62 Million	0.271x	+7.74%
2015-12-31	CN¥97.42 Million ≈ $14.26 Million	CN¥24.54 Million ≈ $3.59 Million	0.252x	-20.82%
2014-12-31	CN¥55.04 Million ≈ $8.05 Million	CN¥17.51 Million ≈ $2.56 Million	0.318x	+79.38%
2013-12-31	CN¥64.92 Million ≈ $9.50 Million	CN¥11.51 Million ≈ $1.68 Million	0.177x	--

About Zhejiang Tailin Bioengineering Co Ltd

SHE:300813 China Medical Devices

Market Cap

$385.56 Million

CN¥2.63 Billion CNY

Market Cap Rank

#13712 Global

#4111 in China

Share Price

CN¥21.74

Change (1 day)

-0.96%

52-Week Range

CN¥17.08 - CN¥37.01

All Time High

CN¥64.43